WebJun 28, 2024 · Rapidly progressive glomerulonephritis (RPGN) is a disease of the kidney characterized clinically by a rapid decrease in the glomerular filtration rate (GFR) of at … WebThe effects of MP + CTX therapy on improving renal dysfunctions may partially contribute to its amelioration of infiltrating cells in renal tissues. The degrees of CD4+, CD68+, and PCNA+ cells in the kidney may be useful indicators of MP + CTX therapy for RPGN. MeSH terms Adult Anti-Inflammatory Agents / administration & dosage*
Rapidly Progressive Glomerulonephritis - an overview
WebMethods: The efficacy and toxicity of i.v. pulse administration of CYC (0.75 gm/m2) versus daily oral CYC treatment (2 mg/kg body weight) were investigated in a prospective, randomized, multicenter study in patients with ANCA-associated vasculitis and … WebSep 26, 2024 · Intravenous cyclophosphamide (IVCY) pulse therapy is recommended (recommendation grade 2D) for the initial treatment of ANCA-associated RPGN rather than oral cyclophosphamide (POCY). Summary: Both POCY and IVCY are effective for remission induction; however, IVCY is considered slightly superior to POCY in terms of … great courses joy of thinking
Kidney and Dialysis Free Full-Text Should We Still Use …
WebApr 15, 2024 · A positive culture was obtained for Aspergillus fumigatus, and she was diagnosed with Aspergillus endophthalmitis, which was developed following 7 days … WebCyclophosphamide is one of a number of medications first developed as a chemotherapy drug (a medication used in the treatment of cancer). It was discovered that — in addition to its usefulness in cancer — cyclophosphamide also has a significant ability to suppress the immune system. WebMonthly Cyclophosphamide Pulses in the Treatment of Crescentic Glomerulonephritis M. De La Torre, R. Alca´zar, J.M. Urra, G. Caparro´s, R. Alegre, J. Blanco, J. Nieto, and I. Ferreras A CUTE crescentic rapidly progressive glomerulone- phritis (AC-RPGN) is a heterogeneous group of diseases characterised by a distinct clinicopathologic pre- quent … great courses issues with app